Sertaconazole in the treatment of mycoses: from dermatology to gynecology (Q34105389)

31 July 2017

1 reference

title

Sertaconazole in the treatment of mycoses: from dermatology to gynecology (English)

1 reference

31 July 2017

J Torres

1

1 reference

31 July 2017

M Márquez

series ordinal

2

1 reference

31 July 2017

F Camps

series ordinal

3

1 reference

31 July 2017

publication date

1 December 2000

1 reference

International Journal of Gynecology and Obstetrics

31 July 2017

published in

1 reference

31 July 2017

volume

71 Suppl 1

1 reference

31 July 2017

page(s)

S3-20

1 reference

Epidemiology of vaginitis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Evolving pathogens in vulvovaginal candidiasis: implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Vulvovaginitis: the role of patient compliance in treatment success

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Treatment options for vulvovaginal candidiasis, 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Stevens-Johnson syndrome after fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Angio-oedema after fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Hepatic injury associated with itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

One-dose therapy of Candida vaginitis. I. Results of an open multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Systemic absorption of miconazole from the vagina

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Vaginal secretion levels after 6 days, 3 days and 1 day of treatment with 100, 200 and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Efficacy and tolerability of single-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

Vaginal infections in adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900349-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7292(00)00349-0

1 reference

31 July 2017

1 reference